急性重型肝炎

  • 网络Acute Severe Hepatitis;acute fulminant hepatitis;ASH;alf
急性重型肝炎急性重型肝炎
  1. 目的总结急性重型肝炎的治疗经验。

    Objective To enhance the cure rate of acute severe hepatitis .

  2. 急性重型肝炎患者凝血及血小板测定的临床意义

    The Clinical Significance Of Blood Coagulation Ang Platelet Measurement for Patients with Acute Severe Hepatitis

  3. 按照慢性乙型肝炎、亚急性重型肝炎、肝硬化的顺序,C基因型的检出率逐渐增多,B基因型的检出率逐渐减少。

    The detection rate of genotype C increased according to the sequence of chronic hepatitis B , subacute severe hepatitis and hepatocirrhosis while the detection rate of genotype B decreased gradually .

  4. HGV感染可能与一些急性重型肝炎发病有关。

    Our results support that HGV infection is associated with some Acute fulminant hepatitis .

  5. 结果7例亚急性重型肝炎病人的HBV分离株CP区分别有2~12个替代变异,1例病人有11bp的碱基插入。

    Results There were 2 12 nucleotide substitutions in CP region in the 7 subacute fulminant hepatitis patients studied . An 11 bp nucleotides insertion was found in one patient .

  6. 亚急性重型肝炎与急性肝炎血清IAP水平间比较采用t检验,血清IAP对亚急性重型肝炎与急性肝炎的鉴别价值分析采用ROC曲线法。

    ROC curve was used for analyzing the value of serum IAP levels in discriminating subacute severe hepatitis from acute hepatitis .

  7. 结果治疗时机、病人年龄、血清胆红素、PTA、重叠感染及严重的并发症是亚急性重型肝炎死亡的重要原因。

    Results The causes of death in these patients were related to the time to be treated , patients'age , serum bilirubin and phospho-transacetylase , overlapping infectious and severe complications .

  8. 然而慢性持续性肝炎组、慢性活动性肝炎组及亚急性重型肝炎组门管区内FN含量与正常肝组比较均有所增多。

    On the contrary , however , the FN content in portal triads in the chronic persistent hepatitis , chronic active hepatitis and subacute severe hepatitis groups increased in comparison with that of the normal liver group .

  9. 亚急性重型肝炎和慢性重型肝炎的MAO分别为57.4U±14.9U和58.9U±16.8U,与其他肝炎各组相比差异有显著性(P<0.01)。

    The mean value of MAO of patients with severe subacute hepatitis and . Severe chronic hepatitis were 57.4 U ± 14.9 U and 58.9 U ± 16.8 U respectively , significantly higher than those in other hepatitis groups ( P < 0.01 ) .

  10. 亚急性重型肝炎病理炎症分期的研究

    A study of the Pathologic Inflammatory Phase of Severe Subacute Hepatitis

  11. 亚急性重型肝炎分腹水型及脑病型;④亚急性重型肝炎及慢性重型肝炎仍应区分为早期、中期及晚期。

    Subacute severe hepatitis be divided into encephalopathy and ascite type .

  12. 综合治疗加血浆置换治疗亚急性重型肝炎的疗效探讨

    Therapeutic effect of combined treatment with plasma exchange on severe subacute hepatitis

  13. 亚急性重型肝炎的肝脏血流动力学改变

    Hemodynamic changes of liver in patients with subacute severe hepatitis

  14. 血清免疫抑酸性蛋白对亚急性重型肝炎的诊断意义

    Diagnostic significance of serum immunosuppressive acidic protein level for subacute severe hepatitis

  15. 亚急性重型肝炎52例临床分析

    Analysis on 52 cases of subacute severe type hepatitis

  16. 原位肝移植治疗急性重型肝炎的效果评价

    To evaluate the effects of orthotopic liver transplantation in the treatment of fulminating hepatitis

  17. 亚急性重型肝炎分型与分型治疗探讨

    Clinical Types and Treatment for Severe Subacute Hepatitis

  18. 急性重型肝炎的主要病变为肝细胞的急性广泛坏死(大块、亚大块或桥接坏死),坏死>2/3者,多不能存活;

    The main lesion in the liver of ASH is an one attack of massive or submassive hepatic necrosis .

  19. 胸腺肽、胰高血糖素-胰岛素和支链氨基酸综合治疗亚急性重型肝炎研究

    A Study of Synthetic Treatment with Thymic Peptide . Glucagon-Insulin and Branch Amino acid in Subacute Severe Viral Hepatitis

  20. 结果人工肝支持系统中血浆置换治疗重型肝炎总有效率为63%,尤以急性重型肝炎和亚急性重型肝炎的好转较明显。

    Results The total efficient rate of plasma-exchange therapy in artificial liver system was 63 % . And the curative effect in acute and subacute severe hepatitis is better than that in chronic severe hepatitis .

  21. 患者从发病(入院)到PT>120s的时间为1~112d,平均20.4±24.3d,其中以急性重型肝炎和亚急性重型肝炎最短,慢性重型肝炎相对较长;

    The time from patient breaking out to PT > 120 s was 1-112 days , mean 20.4 ± 24.3 days , for which acute severe hepatitis was the shortest , chronic severe hepatitis was the longest .

  22. 患者从PT>120s到死亡(无效)的时间为1~10d,平均2.5±2.2d,其中急性重型肝炎和亚急性重型肝炎以及肝硬化失代偿均在1~2d内死亡或者放弃治疗;

    The time from PT > 120 s to patient death was 1-10 days , mean 2.5 ± 2.2 days , for which acute severe hepatitis and liver cirrhosis were 1-2 days , chronic severe hepatitis was 1-10 days .

  23. 急性乙型重型肝炎组HBVcore18-27特异性CTL裂解靶细胞能力高于慢性乙型重型肝炎组(P<0.05)。

    The ability to lyse target cells of HBV core 18-27 CTLs was also significantly higher in the acute severe hepatitis B group than that in the chronic severe hepatitis B group ( P < 0.05 ) .

  24. 结果急性重型乙型肝炎组、亚急性重型乙型肝炎组、慢性重型乙型肝炎组血清TBA水平显著高于对照组(P<0.001);

    Results The level of serum total bile acids in acute grave hepatitis B group , subacute grave hepatitis B group and chronic grave hepatitis B group were significantly higher than that in control group ( P < 0.001 ) .

  25. 结果急性乙型重型肝炎组外周血中针对HBVcore18-27表位的特异性CTL数量高于慢性乙型重型肝炎组(P<0.05),而低于急性乙型肝炎组(P<0.05);

    Results The number of HBV core 18-27 specific CD8 + T cells was significantly higher in the peripheral blood of acute severe hepatitis B group patients than that in chronic severe hepatitis group ( P < 0.05 ), but lower than that in the acute hepatitis B patients .

  26. 高原地区儿童急性甲型重型肝炎1例

    Children acute serious HAV in plateau section : one case report

  27. 血清胆碱酯酶活性对诊断亚急性乙型重型肝炎的价值探讨

    Early predictive value of serum cholinesterase for subacute severe hepatitis

  28. 急性肝炎、重型肝炎和肝硬化HDAg(+)、HBeAg(-)表达高于HDAg、HBeAg均阳性者(P<0.01或P<0.05)。

    In patients with acute hepatitis , severe hepatitis , and liver cirrhosis , the expression of positive HDAg and negative HBeAg was obviously higher than that of positive HDAg and HBeAg ( P < 0.01 or P < 0.05 ) .

  29. 亚急性及慢性重型肝炎以乙型肝炎病毒感染居首位,占92.8%。

    Infection of HBV leads to 92.8 % sub - acute severe hepatitis and chronic severe hepatitis .

  30. HGV感染在肝炎各临床类型分布为急性、慢性和重型肝炎患者无明显差异,且无性别和年龄分布的差异。

    HGV infecting rate showed no difference concerning clinical type of hepatitis as well as sex and age .